Highlighting our most cited articles from past issues.

2018 |
2017 |
2016 |
2015 |
2014 |
2013 |
Top of page

: 2018Top of page

January

Twenty years ago this month:
Smith GS, Schloesser R, Brodie JD et al (1998). Glutamate modulation of dopamine measured in vivo with positron emission tomography (PET) and C-11-raclopride in normal human subjects. Neuropsychopharmacology 18:18-25 (Times cited: 146)

Ten years ago this month:
Quirk GJ, Mueller D (2008). Neural mechanisms of extinction learning and retrieval. Neuropsychopharmacology 33:56-72 (Times cited: 775)

Five years ago this month:
Moore LD, Le T, Fan G (2013). DNA Methylation and Its Basic Function. Neuropsychopharmacology 38:23-38 (Times cited: 166)

February

Twenty years ago this month:
Arnt J, Skarsfeldt T (1998). Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence. Neuropsychopharmacology 18:63-101 (Times cited: 580)

Ten years ago this month:
Walker BM, Koob GF (2008). Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence. Neuropsychopharmacology 33:643-652 (Times cited: 211)

Five years ago this month:
Cattaneo A, Gennarelli M, Uher R et al(2013). Candidate Genes Expression Profile Associated with Antidepressants Response in the GENDEP Study: Differentiating between Baseline 'Predictors' and Longitudinal 'Targets'. Neuropsychopharmacology 38:377-385 (Times cited: 126)

March

Twenty years ago this month:
Markou A, Kosten TR, Koob GF (1998). Neurobiological similarities in depression and drug dependence: A self-medication hypothesis. Neuropsychopharmacology 18:135-174 (Times cited: 487)

Ten years ago this month:
Markram K, Rinaldi T, La Mendola D et al (2008). Abnormal fear conditioning and amygdala processing in an animal model of autism. Neuropsychopharmacology 33:901-912 (Times cited: 138)

Five years ago this month:
Baumann MH, Partilla JS, Lehner KR et al (2013). Powerful Cocaine-Like Actions of 3,4-Methylenedioxypyrovalerone (MDPV), a Principal Constituent of Psychoactive 'Bath Salts' Products. Neuropsychopharmacology 38:552-562 (Times cited: 146)

April

Twenty years ago this month:
Modell S, Lauer CJ, Schreiber W et al (1998). Hormonal response pattern in the combined DEX-CRH test is stable over time in subjects at high familial risk for affective disorders. Neuropsychopharmacology 18:253-262 (Times cited: 154)

Ten years ago this month:
Robinson ESJ, Eagle DM, Mar AC et al (2008). Similar effects of the selective noradrenaline reuptake inhibitor atomoxetine on three distinct forms of impulsivity in the rat. Neuropsychopharmacology 33:1028-1037 (Times cited: 175)

Five years ago this month:
Burgdorf J, Zhang X, Nicholson KL et al (2013). GLYX-13, a NMDA Receptor Glycine-Site Functional Partial Agonist, Induces Antidepressant-Like Effects Without Ketamine-Like Side Effects. Neuropsychopharmacology 38:729-742 (Times cited: 119)

Top of page

: 2017Top of page

January

Twenty years ago this month:
Nyberg S, Farde L, Halldin C (1997). A PET study of 5-HT2 and D-2 dopamine receptor occupancy induced by olanzapine in healthy subjects. Neuropsychopharmacology 16:1-7 (Times cited: 108)

Ten years ago this month:
Pichat P, Bergis OE, Terranova JP et al (2007). SSR180711, a novel selective alpha 7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia. Neuropsychopharmacology 32:17-34 (Times cited: 179)

Five years ago this month:
Haroon E, Raison CL, Miller AH (2012). Psychoneuroimmunology Meets Neuropsychopharmacology: Translational Implications of the Impact of Inflammation on Behavior. Neuropsychopharmacology 37:137-162 (Times cited: 235)

February

Twenty years ago this month:
Seeman P, Corbett R, VanTol HHM (1997). Atypical neuroleptics have low affinity for dopamine D-2 receptors or are selective for D-4 receptors. Neuropsychopharmacology 16:93-110 (Times cited: 166)

Ten years ago this month:
Chanraud S, Martelli C, Delain F et al (2007). Brain morphometry and cognitive performance in detoxified alcohol-dependents with preserved psychosocial functioning . Neuropsychopharmacology 32:429-438 (Times cited: 153)

Five years ago this month:
Shim JC, Jung DU, Jung SS et al (2012). Adjunctive Varenicline Treatment with Antipsychotic Medications for Cognitive Impairments in People with Schizophrenia: A Randomized Double-Blind Placebo-Controlled Trial. Neuropsychopharmacology 37:660-668 (Times cited: 55)

March

Twenty years ago this month:
Chen G, Yan PX, Hawver DB et al (1997). Increase in AP-1 transcription factor DNA binding activity by valproic acid. Neuropsychopharmacology 16:238-245 (Times cited: 63)

Ten years ago this month:
Ellgren M, Spano SM, Hurd YL (2007). Adolescent cannabis exposure alters opiate intake and opioid limbic neuronal populations in adult rats. Neuropsychopharmacology 32:607-615 (Times cited: 105)

Five years ago this month:
Zunszain PA, Anacker C, Cattaneo A et al (2012). Interleukin-1 beta: A New Regulator of the Kynurenine Pathway Affecting Human Hippocampal Neurogenesis. Neuropsychopharmacology 37:939-949 (Times cited: 101)

April

Twenty years ago this month:
Wan RQ, Corbett R (1997). Enhancement of postsynaptic sensitivity to dopaminergic agonists induced by neonatal hippocampal lesions. Neuropsychopharmacology 16:259-268 (Times cited: 54)

Ten years ago this month:
Du J, Suzuki K, Wei Y et al (2007). The anticonvulsants lamotrigine, riluzole, and valproate differentially regulate AMPA receptor membrane localization: Relationship to clinical effects in mood disorders. Neuropsychopharmacology 32:793-802 (Times cited: 116)

Five years ago this month:
Baumann MH, Ayestas MA, Partilla et al (2012). The Designer Methcathinone Analogs, Mephedrone and Methylone, are Substrates for Monoamine Transporters in Brain Tissue. Neuropsychopharmacology 37:1192-1203 (Times cited: 149)

May

Twenty years ago this month:
Vollenweider FX, Leenders KL, Scharfetter C et al (1997). Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis. Neuropsychopharmacology 16:357-372 (Times cited: 164)

Ten years ago this month:
Apud JA, Mattay V, Chen JS et al (2007). Tolcapone improves cognition and cortical information processing in normal human subjects. Neuropsychopharmacology 32:1011-1020 (Times cited: 126)

Five years ago this month:
Ibrahim L, DiazGranados N, Franco-Chaves J et al (2012). Course of Improvement in Depressive Symptoms to a Single Intravenous Infusion of Ketamine vs Add-on Riluzole: Results from a 4-Week, Double-Blind, Placebo-Controlled Study. Neuropsychopharmacology 37:1526-1533 (Times cited: 99)

June

Twenty years ago this month:
Lewis DA (1997). Development of the prefrontal cortex during adolescence: Insights into vulnerable neural circuits in schizophrenia. Neuropsychopharmacology 16:385-398 (Times cited: 204)

Ten years ago this month:
Dahan L, Astier B, Vautrelle N et al (2007). Prominent burst firing of dopaminergic neurons in the ventral tegmental area during paradoxical sleep. Neuropsychopharmacology 32:1232-1241 (Times cited: 88)

Five years ago this month:
D'Addario C, Dell'Osso B, Palazzo MC et al (2012). Selective DNA Methylation of BDNF Promoter in Bipolar Disorder: Differences Among Patients with BDI and BDII. Neuropsychopharmacology 37:1647-1655 (Times cited: 58)

July

Twenty years ago this month:
Ehlers CL, Somes C, Lopez A et al (1997). Electrophysiological actions of neuropeptide Y and its analogs: New measures for anxiolytic therapy?. Neuropsychopharmacology 17:34-43 (Times cited: 64)

Hertel P, Nomikos GG, Schilstrom B et al (1997). Risperidone dose-dependently increases extracellular concentrations of serotonin in the rat frontal cortex: Role of alpha(2)-adrenoceptor antagonism. Neuropsychopharmacology 17:44-55 (Times cited: 64)

Ten years ago this month:
Czeh B, Mueller-Keuker JIH, Rygula R et al (2007). Chronic social stress inhibits cell proliferation in the adult medial prefrontal cortex: Hemispheric asymmetry and reversal by fluoxetine treatment. Neuropsychopharmacology 32:1490-1503 (Times cited: 166)

Five years ago this month:
Wittfoth-Schardt D, Grunding J, Wittfoth M et al (2012). Oxytocin Modulates Neural Reactivity to Children's Faces as a Function of Social Salience. Neuropsychopharmacology 37:1799-1807 (Times cited: 47)

August

Twenty years ago this month:
Jentsch JD, Tran A, Le D et al (1997). Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat. Neuropsychopharmacology 17:92-99 (Times cited: 221)

Ten years ago this month:
Bonsi P, Cuomo D, Ding J et al (2007). Endogenous serotonin excites striatal cholinergic interneurons via the activation of 5-HT 2C, 5-HT6, and 5-HT7 serotonin receptors: implications for extrapyramidal side effects of serotonin reuptake inhibitors. Neuropsychopharmacology 32:1840-1854 (Times cited: 81)

Five years ago this month:
Bewernick BH, Kayser S, Sturm V et al (2012). Long-Term Effects of Nucleus Accumbens Deep Brain Stimulation in Treatment-Resistant Depression: Evidence for Sustained Efficacy. Neuropsychopharmacology 37:1975-1958 (Times cited: 104)

September

Twenty years ago this month:
Malhotra AK, Pinals DA, Adler CM et al (1997). Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics. Neuropsychopharmacology 17:141-150 (Times cited: 385)

Ten years ago this month:
Beneyto M, Kristiansen LV, Oni-Orisan A et al (2007). Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders. Neuropsychopharmacology 32:1888-1902 (Times cited: 209)

Five years ago this month:
Shafiei N, Gray M, Viau V et al (2012). Acute Stress Induces Selective Alterations in Cost/Benefit Decision-Making. Neuropsychopharmacology 37:2194-2209 (Times cited: 46)

October

Twenty years ago this month:
Lieberman JA, Sheitman BB, Kinon BJ (1997). Neurochemical sensitization in the pathophysiology of schizophrenia: Deficits and dysfunction in neuronal regulation and plasticity. Neuropsychopharmacology 17:205-229 (Times cited: 252)

Ten years ago this month:
van Haren NEM, Pol HEH, Schnack HG et al (2007). Focal gray matter changes in schizophrenia across the course of the illness: A 5-year follow-up study. Neuropsychopharmacology 32:2057-2066 (Times cited: 179)

Five years ago this month:
Egerton A, Brugger S, Raffin M et al (2012). Anterior Cingulate Glutamate Levels Related to Clinical Status Following Treatment in First-Episode Schizophrenia. Neuropsychopharmacology 37:2515-2521 (Times cited: 57)

November

Twenty years ago this month:
Primus RJ, Yevich E, Baltazar C et al (1997). Autoradiographic localization of CRF1 and CRF2 binding sites in adult rat brain. Neuropsychopharmacology 17:308-316 (Times cited: 122)

Ten years ago this month:
Franklin TR, wang Z, Wang J et al (2007). Limbic activation to cigarette smoking cues independent of nicotine withdrawal: A perfusion fMRI study. Neuropsychopharmacology 32:2301-2309 (Times cited: 192)

Five years ago this month:
Rey AA, Purrio M, Viveros M et al (2012). Biphasic Effects of Cannabinoids in Anxiety Responses: CB1 and GABA(B) Receptors in the Balance of GABAergic and Glutamatergic Neurotransmission. Neuropsychopharmacology 37:2624-2634 (Times cited: 75)

December

Twenty years ago this month:
Sundstrom I, Nyberg S, Backstrom T (1997). Patients with premenstrual syndrome have reduced sensitivity to midazolam compared to control subjects. Neuropsychopharmacology 17:370-381 (Times cited: 90)

Ten years ago this month:
Frye MA, Watzl J, Banakar S et al (2007). Increased anterior cingulate/medial prefrontal cortical glutamate and creatine in bipolar depression. Neuropsychopharmacology 32:2490-2499 (Times cited: 104)

Five years ago this month:
Cai K, Nanga RPR, Lamprou L et al (2012). The Impact of Gabapentin Administration on Brain GABA and Glutamate Concentrations: A 7T H-1-MRS Study. Neuropsychopharmacology 37:2764-2771 (Times cited: 31)

Top of page

: 2016Top of page

January

Twenty years ago this month:
Azmitia EC, Gannon PJ, Kheck NM, et al (1996). Cellular localization of the 5-HT1A receptor in primate brain neurons and glial cells. Neuropsychopharmacology 14:35-46 (Times cited: 171)

Ten years ago this month:
Maciag D, Simpson KL, Coppinger D, et al (2006). Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry. Neuropsychopharmacology 31:47-57 (Times cited: 131)

Five years ago this month:
Pizzagalli DA (2011). Frontocingulate Dysfunction in Depression: Toward Biomarkers of Treatment Response. Neuropsychopharmacology 36:183-206 (Times cited: 203)

---

February

Twenty years ago this month:
Bymaster FP, Calligaro DO, Falcone JF, et al (1996). Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology 14:87-96 (Times cited: 712)

Ten years ago this month:
Floresco SB, Magyar O, Ghods-Sharifi S, et al (2006). Multiple dopamine receptor subtypes in the medial prefrontal cortex of the rat regulate set-shifting. Neuropsychopharmacology 31:297-309 (Times cited: 198)

Five years ago this month:
Belin D, Berson N, Balado E, et al (2011). High-Novelty-Preference Rats are Predisposed to Compulsive Cocaine Self-administration. Neuropsychopharmacology 36:569-579 (Times cited: 67)

---

March

Twenty years ago this month:
Weinberger DR (1996). On the plausibility of ''The neurodevelopmental hypothesis'' of schizophrenia. Neuropsychopharmacology 14:S1-S11 (Times cited: 99)

Ten years ago this month:
Kosten TR, Scanley BE, Tucker KA, et al (2006). Cue-induced brain activity changes and relapse in cocaine-dependent patients. Neuropsychopharmacology 31:644-650 (Times cited: 128)

Five years ago this month:
Benicky J, Sanchez-Lemus E, Honda, M, et al (2011). Angiotensin II AT(1) Receptor Blockade Ameliorates Brain Inflammation. Neuropsychopharmacology 36:857-870 (Times cited: 55)

---

April

Twenty years ago this month:
Seifritz E, Baumann P, Muller MJ, et al (1996). Neuroendocrine effects of a 20-mg citalopram infusion in healthy males - A placebo-controlled evaluation of citalopram as 5-HT function probe. Neuropsychopharmacology 14:253-263 (Times cited: 88)

Ten years ago this month:
Carli M, Baviera M, Invernizzi RW, et al (2006). Dissociable contribution of 5-HT1A and 5-HT2A receptors in the medial prefrontal cortex to different aspects of executive control such as impulsivity and compulsive perseveration in rats. Neuropsychopharmacology 31:757-767 (Times cited: 115)

Five years ago this month:
Ren WJ, Liu Y, Zhou LI, et al (2011). Peripheral Nerve Injury Leads to Working Memory Deficits and Dysfunction of the Hippocampus by Upregulation of TNF-alpha in Rodents. Neuropsychopharmacology 36:979-992 (Times cited: 58)

---

May

Twenty years ago this month:
Malhotra AK, Pinals DA, Weingartner H, et al (1996). NMDA receptor function and human cognition: The effects of ketamine in healthy volunteers. Neuropsychopharmacology 14:301-307 (Times cited: 408)

Ten years ago this month:
Ersche KD, Clark L, London M, et al (2006). Profile of executive and memory function associated with amphetamine and opiate dependence. Neuropsychopharmacology 31:1036-1047 (Times cited: 116)

Five years ago this month:
Bergamaschi MM, Costa Queiroz RH, Nisihara Chagas MH, et al (2011). Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naive Social Phobia Patients. Neuropsychopharmacology 36:1219-1226 (Times cited: 78)

---

June

Twenty years ago this month:
Mello NK, Negus S (1996). Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures. Neuropsychopharmacology 14:375-424 (Times cited: 260)

Ten years ago this month:
Walf AA, Frye CA (2006). A review and update of mechanisms of estrogen in the hippocampus and amygdala for anxiety and depression behavior. Neuropsychopharmacology 31:1097-1111(Times cited: 175)

Five years ago this month:
Ortega-Alvaro A, Aracil-Fernandez A, Garcia-Gutierrez M et al (2011). Deletion of CB2 Cannabinoid Receptor Induces Schizophrenia-Related Behaviors in Mice. Neuropsychopharmacology 36:1489-1504(Times cited: 50)

---

July

Twenty years ago this month:
Meador-Woodruff JH, Damansk SP, Wang JC et al (1996). Dopamine receptor mRNA expression in human striatum and neocortex. Neuropsychopharmacology 15:17-29 (Times cited: 184)

Ten years ago this month:
Nemeroff CB, Mayberg HS, Krahl SE et al (2006). VNS therapy in treatment-resistant depression: Clinical evidence and putative neurobiological mechanisms. Neuropsychopharmacology 31:1345-1355 (Times cited: 140)

Five years ago this month:
Barrett RM, Malvaez M, Kramar E et al (2011). Hippocampal Focal Knockout of CBP Affects Specific Histone Modifications, Long-Term Potentiation, and Long-Term Memory. Neuropsychopharmacology 36:1545-1556 (Times cited: 73)

---

August

Twenty years ago this month:
Stevens KE, Freedman R, Collins AC et al (1996). Genetic correlation of inhibitory gating of hippocampal auditory evoked response and alpha-bungarotoxin-binding nicotinic cholinergic receptors in inbred mouse strains. Neuropsychopharmacology 15:152-167(Times cited: 178)

Ten years ago this month:
Czeh B, Simon M, Schmelting B et al (2006). Astroglial plasticity in the hippocampus is affected by chronic psychosocial stress and concomitant Fluoxetine treatment. Neuropsychopharmacology 31:1616-1626(Times cited: 168)

Five years ago this month:
Nikolova YS, Ferrell RE, Manuck SB et al (2011). Multilocus Genetic Profile for Dopamine Signaling Predicts Ventral Striatum Reactivity. Neuropsychopharmacology 36:1940-1947(Times cited: 83)

---

September

Twenty years ago this month:
Adinoff B, Anton R, Linnoila M et al (1996). Cerebrospinal fluid concentrations of corticotropin-releasing hormone (CRH) and diazepam-binding inhibitor (DBI) during alcohol withdrawal and abstinence. Neuropsychopharmacology 15:288-295(Times cited: 52)

Ten years ago this month:
Rush A, Kraemer HC, Sackeim HA et al (2006). ). Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacology 31:1841-1853(Times cited: 246)

Five years ago this month:
Chai XJ, Whitfield-Gabrieli S, Shinn AK et al (2011). Abnormal Medial Prefrontal Cortex Resting-State Connectivity in Bipolar Disorder and Schizophrenia. Neuropsychopharmacology 36:2009-2017(Times cited: 97)

---

October

Twenty years ago this month:
Romero L, Bel N, Artigas F et al (1996). Effect of pindolol on the function of pre- and postsynaptic 5-HT1A receptors: In vivo microdialysis and electrophysiological studies in the rat brain. Neuropsychopharmacology 15:349-360 (Times cited: 168)

Ten years ago this month:
Zhu C, Blakely RD, Hewlett WA (2006). The proinflammatory cytokines interleukin-1 beta and tumor necrosis factor-alpha activate serotonin transporters. Neuropsychopharmacology 31:2121-1231 (Times cited: 221)

Five years ago this month:
Lukas M, Toth I, Reber SO et al (2011). The Neuropeptide Oxytocin Facilitates Pro-Social Behavior and Prevents Social Avoidance in Rats and Mice. Neuropsychopharmacology 36:2159-2168 (Times cited: 100)

---

November

Twenty years ago this month:
Levin ED, Wilson W, Rose JE et al (1996). Nicotine-haloperidol interactions and cognitive performance in schizophrenicsNicotine-haloperidol interactions and cognitive performance in schizophrenics. Neuropsychopharmacology 15:429-436 (Times cited: 256)

Ten years ago this month:
Greenberg BD, Malone DA, Friehs GM et al (2006). Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder. Neuropsychopharmacology 31:2384-2393 (Times cited: 321); and Correction to Greenberg BD et al, 2006 (Times cited: 15)

Five years ago this month:
Hannestad J, DellaGioia N, Bloch M (2011). The Effect of Antidepressant Medication Treatment on Serum Levels of Inflammatory Cytokines: A Meta-Analysis. Neuropsychopharmacology 36:2452-2459 (Times cited: 218)

---

December

Twenty years ago this month:
Patchev VK, Hassan AHS, Holsboer F et al (1996). The neurosteroid tetrahydroprogesterone attenuates the endocrine response to stress and exerts glucocorticoid-like effects on vasopressin gene transcription in the rat hypothalamus. Neuropsychopharmacology 15:533-540(Times cited: 175)

Ten years ago this month:
McBride D, Barrett SP, Kelly JT et al (2006). Effects of expectancy and abstinence on the neural response to smoking cues in cigarette smokers: An fMRI study. Neuropsychopharmacology 31:2728-2738(Times cited: 172)

Five years ago this month:
Hanson ND, Owens MJ, Nemeroff CB (2011). Depression, Antidepressants, and Neurogenesis: A Critical Reappraisal. Neuropsychopharmacology 36:2589-2602(Times cited: 88)

Top of page

: 2015Top of page

January

Twenty years ago this month:
In 1995, Neuropsychopharmacology was published eight times a year, so there were no issues in January, March, June, or September.

Ten years ago this month:
Dackis CA, Kampman KM, Lynch KG, et al (2005). A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology 30:205-211 (Times cited: 185)

Five years ago this month:
Koob GF, Volkow ND (2010). Neurocircuitry of Addiction. Neuropsychopharmacology 35:217-238 (Times cited: 789)

---

February

Twenty years ago this month:
Yeomans, JS (1995). Role of tegmental cholinergic neurons in dopaminergic activation, antimuscarinic psychosis and schizophrenia. Neuropsychopharmacology 12:3-16 (Times cited: 143)

Ten years ago this month:
Fuchs RA, Evans KA, Ledford CC, et al (2005). The role of the dorsomedial prefrontal cortex, basolateral amygdala, and dorsal hippocampus in contextual reinstatement of cocaine seeking in rats. Neuropsychopharmacology 30:296-309 (Times cited: 218)

Five years ago this month:
Fineberg NA, Potenza MN, Chamberlain SR, et al (2010). Probing Compulsive and Impulsive Behaviors, from Animal Models to Endophenotypes: A Narrative Review. Neuropsychopharmacology 35:591-604 (Times cited: 149)

---

March

Twenty years ago this month:
In 1995, Neuropsycopharmacology was published eight times a year, so there were no issues in January, March, June, or September.

Ten years ago this month:
Chhatwal JP, Davis M, Maguschak KA, et al (2005). Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear. Neuropsychopharmacology 516-524 (Times cited: 183)

Five years ago this month:
Kilgore M, Miller CA, Fass DM, et al (2010). Inhibitors of Class 1 Histone Deacetylases Reverse Contextual Memory Deficits in a Mouse Model of Alzheimer's Disease. Neuropsychopharmacology 35:870-880 (Times cited: 195)

---

April

Twenty years ago this month:
Eriksson E, Hedberg MA, Andersch B, et al (1995). The serotonin reuptake inhibitor paroxetin is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual-syndrome. Neuropsychopharmacology 12:167-176 (Times cited: 148)

Ten years ago this month:
Winstanley CA, Theobald DEH, Dalley JW, et al (2005). Interactions between serotonin and dopamine in the control of impulsive choice in rats: Therapeutic implications for impulse control disorders. Neuropsychopharmacology 30:669-682 (Times cited: 144)

Five years ago this month:
Terracciano A, Tanaka T, Sutin AR, et al (2010). BDNF Val66Met is Associated with Introversion and Interacts with 5-HTTLPR to Influence Neuroticism. Neuropsychopharmacology 35:1083-1089 (Times cited: 39)

---

May

Twenty years ago this month:
Thase ME, Trivedi MH, Rush AJ (1995). Maois in the contemporary treatment of depression. Neuropsychopharmacology 12:185-219 (Times cited: 140)

Ten years ago this month:
O'Brien MS, Anthony JC (2005). Risk of becoming cocaine dependent: Epidemiological estimates for the United States, 2000-2001. Neuropsychopharmacology 30:1006-1018 (Times cited: 100)

Five years ago this month:
Soria V, Martinez-Amoros E, Escaramis G, et al (2010). Differential Association of Circadian Genes with Mood Disorders: CRY1 and NPAS2 are Associated with Unipolar Major Depression and CLOCK and VIP with Bipolar Disorder. Neuropsychopharmacology 35:1279-1289 (Times cited: 94)

---

June

Twenty years ago this month:
In 1995, Neuropsychopharmacology was published eight times a year, so there were no issues in January, March, June, or September.

Ten years ago this month:
Thal LJ, Ferris SH, Kirby L, et al (2005). A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment. Neuropsychopharmacology 30:1204-1215 (Times cited: 216)

Five years ago this month:
Maayan L, Vakhrusheva J Correll CU (2010). Effectiveness of Medications Used to Attenuate Antipsychotic-Related Weight Gain and Metabolic Abnormalities: A Systematic Review and Meta-Analysis. Neuropsychopharmacology 35:1520-1530 (Times cited: 69)

---

July

Twenty years ago this month:
Burris KD, Pacheco MA, Filtz M, et al (1995). Lack of Discrimination by Agonists for D2 and D3 Dopamine Receptors. Neuropsychopharmacology 12:335-345 (Times cited: 90)

Ten years ago this month:
Gould TD, Manji HK (2005). Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs. Neuropsychopharmacology 30:1223-1237 (Times cited: 202)

Five years ago this month:
Xie P, Kranzler HR, Poling J, et al (2010). Interaction of FKBP5 with Childhood Adversity on Risk for Post-Traumatic Stress Disorder. Neuropsychopharmacology 35:1684-1692 (Times cited: 106)

---

August

Twenty years ago this month:
Lahti AC, Koffel B, LaPorte D, et al (1995). Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology 13:9-19 (Times cited: 471)

Ten years ago this month:
Zhang XY, Zhou DF, Cao LY, et al (2005). Cortisol and cytokines in chronic and treatment-resistant patients with schizophrenia: Association with psychopathology and response to antipsychotics. Neuropsychopharmacology 30:1532-1538 (Times cited: 77)

Five years ago this month:
Nielsen J, Skadhede S, Correll CU (2010). Antipsychotics Associated with the Development of Type 2 Diabetes in Antipsychotic-Naive Schizophrenia Patients. Neuropsychopharmacology 35:1997-2004 (Times cited: 68)

---

September

Twenty years ago this month:
In 1995, Neuropsychopharmacology was published eight times a year, so there were no issues in January, March, June, or September.

Ten years ago this month:
Dorph-Petersen KA, Pierri JN, Perel JM, et al (2005). The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: A comparison of haloperidol and olanzapine in macaque monkeys. Neuropsychopharmacology 30:1649-1661 (Times cited: 138)

Five years ago this month:
McCallum J, Kim JH, Richardson R (2010). Impaired Extinction Retention in Adolescent Rats: Effects of D-Cycloserine. Neuropsychopharmacology 35:2134-2142 (Times cited: 51)

---

October

Twenty years ago this month:
Elmansari M, Bouchard C, Blier P (2005). Alteration Of Serotonin Release In The Guinea-Pig Orbitofrontal Cortex By Selective Serotonin Reuptake Inhibitors - Relevance To Treatment Of Obsessive-Compulsive Disorder. Neuropsychopharmacology 13:117-127 (Times cited: 83)

Ten years ago this month:
Lee PR, Brady DL, Shapiro RA, et al (2005). Social interaction deficits caused by chronic phencyclidine administration are reversed by oxytocin. Neuropsychopharmacology 30:1883-1894 (Times cited: 104)

Five years ago this month:
Li X, Jope RS (2010). Is Glycogen Synthase Kinase-3 a Central Modulator in Mood Regulation? Neuropsychopharmacology 35:2143-2154 (Times cited: 107)

---

November

Twenty years ago this month:
Brunello N, Masotto C, Steardo L, et al (1995). New insights into the biology of schizophrenia through the mechanism of action of clozapine. Neuropsychopharmacology 13:177-213 (Times cited: 159)

Ten years ago this month:
Steen RG, Hamer RM, Lieberman JA (2005). Measurement of brain metabolites by H-1 magnetic resonance spectroscopy in patients with review and meta-analysis. Neuropsychopharmacology 30: 1949-1962 (Times cited: 164)

Five years ago this month:
Schmdt HD, Duman RS (2010). Peripheral BDNF Produces Antidepressant-Like Effects in Cellular and Behavioral Models. Neuropsychopharmacology 35:2378-2391 (Times cited: 133)

---

December

Twenty years ago this month:
Herman BH, Vocci F, Bridge P (1995). The effects of NMDA receptor antagonists and nitric-oxide synthase inhibitors on opiod tolerance and withdrawal – medication development issues for opiate addiction. Neuropsychopharmacology 13: 269-293 (Times cited: 143)

Ten years ago this month:
Plotsky PM, Thrivikraman KV, Nemeroff CB et al. (2005). Long-term consequences of neonatal rearing on central corticotropin-releasing factor systems in adult male rat offspring. Neuropsychopharmacology 30: 2192-2204 (Times cited: 245)

Five years ago this month:
Carpenter LL, Gawuga CE, Tyrka AR et al (2010). Association between plasma IL-6 response to acute stress and early-life adversity in healthy adults. Neuropsychopharmacology 35: 2617-2623 (Times cited: 82)

Top of page

: 2014Top of page

Top of page

: 2013Top of page